(Q36094535)

12 August 2017

1 reference

title

Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations (English)

1 reference

12 August 2017

Katherine L Widnell

1

1 reference

12 August 2017

Cynthia Comella

series ordinal

2

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

20 Suppl 11

1 reference

12 August 2017

page(s)

S30-7

1 reference

Heart valvular disease in patients with Parkinson’s disease treated with high-dose pergolide

12 August 2017

cites work

1 reference

Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease. International Pramipexole-Bromocriptine Study Group.

21 January 2018

1 reference

Subcutaneously administered apomorphine: pharmacokinetics and metabolism

21 January 2018

1 reference

Multicenter study of cabergoline, a long-acting dopamine receptor agonist, in Parkinson's disease patients with fluctuating responses to levodopa/carbidopa.

21 January 2018

1 reference

Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole

21 January 2018

1 reference

Ropinirole and pramipexole, the new agonists

21 January 2018

1 reference

Developmental apraxia arising from neonatal brachial plexus palsy.

21 January 2018

1 reference

Catechol-O-methyltransferase inhibitor tolcapone prolongs levodopa/carbidopa action in parkinsonian patients.

21 January 2018

1 reference

Tolcapone in stable Parkinson's disease: efficacy and safety of long-term treatment. The Tolcapone Stable Study Group

21 January 2018

1 reference

Safety and tolerability of COMT inhibitors

21 January 2018

1 reference

Levodopa/carbidopa/entacapone (Stalevo).

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.20461

1 reference

12 August 2017

1 reference